This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignee: Bellco S.r.l.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations in Myeloma Treatment: The Contributions of Mauro Atti
Introduction
Mauro Atti is a distinguished inventor based in Bologna, Italy, known for his significant contribution to the treatment of myeloma patients. With one patent to his name, Atti’s work focuses on advancing medical technology that offers hope to those affected by this challenging condition.
Latest Patents
Mauro Atti's patent, titled "Kit, system and method of treating myeloma patients," addresses critical aspects of the pathogenesis of acute renal failure due to myeloma. This innovative method utilizes circulating free lambda and kappa free light chains in blood, which play a crucial role in the disease's progression. The patent showcases a unique approach involving coupled plasma filtration and adsorption, allowing effective separation of plasma from blood. The treatment process includes a cartridge filled with sorbent or resin materials, specifically hydrophobic divinylbenzene styrenic resins, characterized by an average bead diameter of 75 microns, an average pore diameter of 30 nm, and a substantial surface area of 700 m²/g. As a result of this treatment, lambda and kappa free light chain concentrations significantly decrease throughout the process, leading to marked improvements in patient outcomes by the end of the treatment.
Career Highlights
Atti is currently associated with Bellco S.r.l., a company dedicated to developing innovative medical solutions. His work in this organization reflects his commitment to enhancing patient care through technological advancements in healthcare.
Collaborations
Throughout his career, Mauro Atti has collaborated with esteemed colleagues, including Mary Lou Wratten and Antonio Santoro. Their collective expertise and dedication to research and development have contributed to the successful implementation and validation of Atti's patent, fostering a promising future for myeloma treatment strategies.
Conclusion
Mauro Atti’s innovative work in the field of myeloma treatment exemplifies the profound impact of medical inventions on patient care. His patent represents a significant step forward in understanding and addressing the complexities of myeloma, showcasing the potential of scientific advancements to change lives for the better. As the landscape of medical technology continues to evolve, inventors like Mauro Atti remain at the forefront, driving progress and offering hope to patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile